Daxor Corporation Awarded $1.1 Million Contract from the United States Defense Health Agency for Added Capabilities to its Point-of-Care Blood Volume Analyzer
05 juil. 2023 08h00 HE
|
Daxor Corporation
Oak Ridge, TN, July 05, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announced that the United States Defense Health...
Daxor Corporation to Showcase the Benefits of BVA-100® Guided Care at the American Association of Heart Failure Nurses (AAHFN) 19th Annual Meeting
20 juin 2023 08h00 HE
|
Daxor Corporation
Oak Ridge, TN, June 20, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will exhibit at the American...
Daxor Accelerates Blood Volume Analysis Adoption with the Launch of ezBVA Lab Services
15 juin 2023 08h00 HE
|
Daxor Corporation
Daxor’s ezBVA Lab Designed to Drive Greater Prescriber Access and Utilization Across the United States Oak Ridge, TN, June 15, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global...
Daxor Corporation Announces Closing of $4.0 Million Underwritten Public Offering
25 mai 2023 15h37 HE
|
Daxor Corporation
Oak Ridge, TN, May 25, 2023 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the closing of...
Daxor Corporation Announces Pricing of $4.0 Million Underwritten Public Offering
22 mai 2023 08h30 HE
|
Daxor Corporation
Oak Ridge, TN, May 22, 2023 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the pricing of...
New Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in Heart Failure Outcomes
18 mai 2023 08h00 HE
|
Daxor Corporation
Daxor’s BVA Technology Shown to Provide Unique and Individualized Data for Patient Management Oak Ridge, TN, May 18, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader...
New Studies Presented at the 43rd International Society for Heart and Lung Transplant Validate the Applicability of the BVA-100® Blood Test for Patients with Advanced Heart Failure
20 avr. 2023 08h00 HE
|
Daxor Corporation
Study Demonstrates BVA Provides More Accurate Congestion Measurement in Challenging Patient Populations Oak Ridge, TN, April 20, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global...
Daxor Corporation to Exhibit at the MedAxiom Cardiovascular Transforum Conference Spring’23 to Advance Awareness and Further Adoption of Daxor’s Blood Volume Diagnostic (BVA-100®)
17 avr. 2023 08h00 HE
|
Daxor Corporation
Expert Users to Present “Blood Volume Analysis – Breaking the Heart Failure Cycle” Oak Ridge, TN, April 17, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood...
Daxor Corporation to Exhibit at the 43rd International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions
13 avr. 2023 08h00 HE
|
Daxor Corporation
Company to Showcase Three New Research Studies Utilizing Blood Volume Analysis Oak Ridge, TN, April 13, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume...
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
03 mars 2023 08h00 HE
|
Daxor Corporation
Oak Ridge, TN, March 03, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today issued a corporate update in a Letter to...